Orano acquires CERIS Group to develop its activities in the healthcare, pharmaceuticals and biotechnology sectors
The Orano group today announced that Orano Projets has acquired a majority stake in CERIS Group, which operates in the healthcare and life science sectors as well as in industries subject to severe constraints.
This acquisition will enable Orano Projets to accelerate the development of complementary know-how and new locations, in particular in Nantes and Lyon where CERIS Group is already established. Orano Projets will also benefit from a broadened product and service offering in the field of engineering, design and construction for industrial projects in the healthcare-pharmaceuticals and biotechnology sectors.
CERIS Group employs around 50 people in France. Orano Projets, with its 1,600 employees worldwide, will strengthen CERIS Group's capacity to respond to its customers' large-scale projects, whether for design and construction phases, service provision or complete turnkey projects.
Specializing in engineering and consulting services, CERIS Group is organized by business line around three subsidiaries: CERIS Ingénierie, Elix and CERIS Architecture. These subsidiaries support their customers in sectors including pharmaceuticals and biotechnology, hospitals and nuclear medicine, as well as for laboratories and other industries subject to severe constraints or highly controlled environments (microelectronics, cosmetics, etc.).
Guillaume Dureau, Chairman of Orano Projets, said "I want to warmly welcome our colleagues from CERIS Group with whom we are about to initiate a new phase of development within Orano Projets. Thanks to this acquisition, Orano Projets is gaining unique skills and know-how in engineering for the healthcare-pharmaceuticals and biotechnology sectors. We are expanding our service offering to provide our customers with even more added value, innovation and performance."
Pascal Giraudeau, CEO of CERIS Group, added "We are delighted to be joining a group with worldwide reach, where we can contribute our special expertise and help Orano Projets to develop in new sectors of activity."
This acquisition will enable Orano Projets to accelerate the development of complementary know-how and new locations, in particular in Nantes and Lyon where CERIS Group is already established. Orano Projets will also benefit from a broadened product and service offering in the field of engineering, design and construction for industrial projects in the healthcare-pharmaceuticals and biotechnology sectors.
CERIS Group employs around 50 people in France. Orano Projets, with its 1,600 employees worldwide, will strengthen CERIS Group's capacity to respond to its customers' large-scale projects, whether for design and construction phases, service provision or complete turnkey projects.
Specializing in engineering and consulting services, CERIS Group is organized by business line around three subsidiaries: CERIS Ingénierie, Elix and CERIS Architecture. These subsidiaries support their customers in sectors including pharmaceuticals and biotechnology, hospitals and nuclear medicine, as well as for laboratories and other industries subject to severe constraints or highly controlled environments (microelectronics, cosmetics, etc.).
Guillaume Dureau, Chairman of Orano Projets, said "I want to warmly welcome our colleagues from CERIS Group with whom we are about to initiate a new phase of development within Orano Projets. Thanks to this acquisition, Orano Projets is gaining unique skills and know-how in engineering for the healthcare-pharmaceuticals and biotechnology sectors. We are expanding our service offering to provide our customers with even more added value, innovation and performance."
Pascal Giraudeau, CEO of CERIS Group, added "We are delighted to be joining a group with worldwide reach, where we can contribute our special expertise and help Orano Projets to develop in new sectors of activity."
Contact
Contact Presse
Press Office
+33 (0)1 34 96 12 15
press@orano.group
+33 (0)1 34 96 12 15
press@orano.group
Contact Investisseur
Quesnoy Marc
investors@orano.group
investors@orano.group